5061 articles
The first disease-specific treatment for Barth syndrome gains FDA accelerated approval, targeting mitochondrial dysfunction to restore muscle strength.
Deleting GTPBP3 in endothelial cells blocks angiogenesis via mtROS overload — and a mitochondria-targeted antioxidant reverses the damage.
A comprehensive review in CA Cancer J Clin maps the molecular biology, treatment strategies, and equity gaps in high-grade serous ovarian cancer.
Mendelian randomization links circulating inflammatory proteins to retinal microvascular changes, heart disease risk, and lifespan — establishing causal direction.
A phase 2b trial finds allogeneic MSC infusions improved 6-minute walk distance by 63 meters vs placebo at 9 months in frail older adults.
A 2025 review maps the molecular mechanisms driving cardiovascular aging—from inflammaging to ECM remodeling—and outlines emerging therapies.
A well-designed trial to reduce added sugar in children's diets raised an unexpected concern: compensatory increases in sodium consumption.
CGM data reveals infants fed corn syrup solid-based formulas show significantly greater glycemic variability than those fed breast milk or lactose-based formula.
Sleep-wake patterns measured by wearables significantly predict dementia risk in 57,000+ older adults, matching the predictive power of genetic testing.
A professional oboist discovered that playing her instrument or singing completely suppressed her debilitating blepharospasm symptoms.
Researchers test a quantile-aggregation approach that may improve how Alzheimer's clinical trials detect treatment effects.
New research reveals how lung cancer subclones develop distinct immune evasion strategies, complicating immunotherapy response.
